Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Gw-597599
2. Gw597599
1. 334476-46-9
2. Vestipitant [inn]
3. Gw597599
4. Gw-597599
5. S052toi9bi
6. (2s)-n-[(1r)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl]-2-(4-fluoro-2-methylphenyl)-n-methylpiperazine-1-carboxamide
7. Unii-s052toi9bi
8. Vestipitant [who-dd]
9. Chembl522987
10. Gtpl5757
11. Schembl2485871
12. Dtxsid50187092
13. Bdbm50413891
14. Db11949
15. Q12747348
16. (2s)-n-[(r)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl]-n-methyl-2-(4-fluoro-2-methylphenyl)-1-piperazinecarboxamide
17. 1-piperazinecarboxamide, N-((1r)-1-(3,5-bis(trifluoromethyl)phenyl)ethyl)-2-(4-fluoro-2-methylphenyl)-n-methyl-, (2s)-
18. 1-piperazinecarboxamide, N-(1-(3,5-bis(trifluoromethyl)phenyl)ethyl)-2-(4-fluoro-2-methylphenyl)-n-methyl-
19. 2(s)-(4-fluoro-2-methyl-phenyl)-piperazine-1-carboxylic Acid [1-(r)-(3,5-bis-trifluoromethyl-phenyl)-ethyl]-methyl-amide
20. 2-(s)-(4-fluoro-2-methyl-phenyl)-piperazine-1 Carboxylic Acid [1-(r)-(3,5-bis-trifluoromethyl-phenyl)-ethyl]-methyl-amide
21. 2-(s)-(4-fluoro-2-methyl-phenyl)-piperazine-1-carboxylic Acid [1-(r)-(3,5-bis-trifluoromethyl-phenyl)-ethyl]-methyl-amide
| Molecular Weight | 491.4 g/mol |
|---|---|
| Molecular Formula | C23H24F7N3O |
| XLogP3 | 4.7 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 3 |
| Exact Mass | 491.18075953 g/mol |
| Monoisotopic Mass | 491.18075953 g/mol |
| Topological Polar Surface Area | 35.6 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 679 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Neurokinin-1 Receptor Antagonists
Compounds that inhibit or block the activity of NEUROKININ-1 RECEPTORS. (See all compounds classified as Neurokinin-1 Receptor Antagonists.)
ABOUT THIS PAGE
85
PharmaCompass offers a list of Vestipitant API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Vestipitant manufacturer or Vestipitant supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Vestipitant manufacturer or Vestipitant supplier.
PharmaCompass also assists you with knowing the Vestipitant API Price utilized in the formulation of products. Vestipitant API Price is not always fixed or binding as the Vestipitant Price is obtained through a variety of data sources. The Vestipitant Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Vestipitant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Vestipitant, including repackagers and relabelers. The FDA regulates Vestipitant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Vestipitant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Vestipitant supplier is an individual or a company that provides Vestipitant active pharmaceutical ingredient (API) or Vestipitant finished formulations upon request. The Vestipitant suppliers may include Vestipitant API manufacturers, exporters, distributors and traders.
Vestipitant Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Vestipitant GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Vestipitant GMP manufacturer or Vestipitant GMP API supplier for your needs.
A Vestipitant CoA (Certificate of Analysis) is a formal document that attests to Vestipitant's compliance with Vestipitant specifications and serves as a tool for batch-level quality control.
Vestipitant CoA mostly includes findings from lab analyses of a specific batch. For each Vestipitant CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Vestipitant may be tested according to a variety of international standards, such as European Pharmacopoeia (Vestipitant EP), Vestipitant JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Vestipitant USP).
